Bayer

Cara Care is a digital health platform focused on improving gut health for individuals with chronic gastrointestinal issues. It offers an app that enables patients to track their dietary habits, symptoms, and emotional states, facilitating a better understanding of their digestive health. By combining behavioral, microbial, and nutritional data, Cara Care empowers over 700,000 patients worldwide to take control of their health. The application allows users to customize their food choices and monitor symptoms such as pain and bloating, helping them identify patterns related to their conditions. This innovative approach goes beyond traditional treatment methods, providing a comprehensive tool for managing chronic digestive disorders in a convenient manner.

Food Banks Canada is a national charitable organization dedicated to helping Canadians living with food insecurity.

Blackford Analysis Ltd. is a software company based in Edinburgh, United Kingdom, that specializes in enhancing the comparison of medical images to improve productivity in healthcare settings. Founded in 2010 as a spin-out from the University of Edinburgh, the company develops a range of tools designed for seamless integration into existing imaging systems. Key products include the Blackford Workflow Server, which facilitates the deployment of pre-processing capabilities within hospital IT frameworks, and the Blackford Smart Localizer, which allows for quick comparisons of multiple imaging studies with a single click. Blackford's software leverages advanced algorithms and multi-core processing technologies to deliver significant time savings—typically between 10% and 20%—for clinicians. The company collaborates with various imaging system providers, such as Philips and Intelerad Medical Systems, as well as industries beyond diagnostic imaging, to enhance diagnostic confidence and patient outcomes. Blackford Analysis continues to expand its presence, with sales offices in the United States and the United Kingdom.

Targenomix is a target identification firm that specializes in elucidating the mode of action of lead molecules within biological systems. The company employs a systems biology approach that integrates various disciplines, including molecular biology, cell biology, genetics, biochemistry, metabolomics, and transcriptomics, supported by advanced data integration and computational biological solutions. This interdisciplinary methodology is positioned as unique in the industry, providing innovative opportunities for companies engaged in the development of small molecules and more complex ingredients, such as biologicals. Targenomix serves clients in the agrochemical, pharmaceutical, and biotechnology sectors, delivering comprehensive research and insights tailored to advance their product development initiatives.

OME Health is a client health support and practice management platform that provides personalized wellness solutions. It enables real-time monitoring of clients' progress by integrating data from various sources, including smart devices, a food diary, and app interactions. The platform is designed to streamline administrative tasks, allowing health professionals to focus more on client needs and their own professional development. Additionally, OME Health offers personalized nutrition programs that incorporate genetic, gut microbiome, and blood testing, along with online health assessments and a complimentary fitness tracker. This comprehensive approach empowers individuals to achieve their health and wellness goals effectively.

Vividion Therapeutics, Inc. is a biotechnology company based in San Diego, California, that focuses on developing innovative therapeutics to address significant unmet medical needs. Established in 2013, Vividion utilizes a pioneering platform for proteome-wide small molecule drug discovery, which combines advanced synthetic chemistry techniques with chemical proteomics. This approach allows the company to expand the druggable proteome and target challenging proteins, ultimately enabling the discovery of transformative treatments for serious illnesses. Vividion's scientific foundation stems from experts in chemical biology and synthetic chemistry at The Scripps Research Institute, reflecting its commitment to advancing therapeutics that can significantly improve patient outcomes.

Noria is a research and development company managed by experienced radiopharmaceutical development leaders and focused on the development of novel targeted alpha therapeutics and theranostic agents.

Elly Health Inc. specializes in developing audio companion software designed for patients, healthcare providers, and organizations. Founded in 2019 and headquartered in Los Angeles, California, the company offers Elly, an innovative empathetic audio companion specifically tailored for individuals managing chronic diseases. This technology aims to motivate and support patients by connecting them with expert advice and community contributions, thereby enhancing their healthcare experience. Elly Health Inc. stands out as a pioneer in the realm of empathetic digital health solutions.

Asklepios BioPharmaceutical is a biotechnology company focused on developing adeno-associated virus (AAV) gene therapies aimed at treating genetic disorders and rare diseases. Established in 2001 and headquartered in Research Triangle Park, North Carolina, the company possesses proprietary AAV technology and manufacturing capabilities, as well as a robust pipeline of clinical programs. Its pipeline includes clinical-stage therapies for Pompe disease and congestive heart failure, alongside a diverse array of preclinical candidates targeting neuromuscular and central nervous system diseases. Additionally, Asklepios has out-licensed clinical indications for hemophilia and Duchenne muscular dystrophy. The company’s gene therapy platform features Pro10, a proprietary cell line manufacturing process, complemented by an extensive library of AAV capsids and promoters, supporting advancements in genetic medicine through global research collaborations and innovative delivery methods.

Care/of is a healthcare technology company based in New York City that focuses on simplifying consumer health through personalized wellness products. The company offers a unique vitamin experience, delivering customized vitamin packs monthly to consumers, tailored to their individual bodies, lifestyles, values, and health objectives. By leveraging its platform, Care/of provides personalized vitamin recommendations based on users' dietary habits and health goals, allowing for a convenient and affordable way to access various vitamins and supplements. Founded on principles of honesty, quality, and personalization, Care/of aims to enhance the health and well-being of its customers through tailored solutions.

KaNDy Therapeutics is a biopharmaceutical company specializing in the development of non-hormonal treatments for various symptoms associated with menopause, including hot flashes and nighttime awakenings. Founded in 2017 and based in Stevenage, United Kingdom, the company focuses on providing effective therapies for moderate to severe post-menopausal vasomotor symptoms. Its lead product, NT-814, addresses chronic debilitating conditions related to female sex hormones, offering a viable alternative for patients seeking relief without hormonal interventions. As a subsidiary of Bayer Aktiengesellschaft, KaNDy Therapeutics aims to improve the quality of life for women experiencing hormone-related challenges.

Litesprite, Inc. is a Bellevue, Washington-based company that develops mobile games aimed at helping individuals manage chronic health conditions, particularly stress, anxiety, and depression. Its flagship product, Sinasprite, is a video game designed to guide users through prescribed mental health treatments, enabling them to track their progress and engage with coping mechanisms in real time. The platform provides valuable data to clinicians, allowing them to understand the effectiveness of various treatment options for their patients. Litesprite's innovative approach combines proven medical treatments with interactive gaming to enhance patient engagement and facilitate communication between patients and healthcare providers. The company aims to create a suite of games addressing various health conditions, leveraging the emotional engagement of gaming to promote better health outcomes. Since its incorporation in 2013, Litesprite has been recognized for its potential to make a significant impact in healthcare, winning accolades such as the Robert Wood Johnson Foundation's Games to Generate Data Challenge.

Upside Health, Inc. is a healthcare technology company based in New York, founded in 2017, that focuses on chronic pain management through its innovative mobile application, Ouchie. This application provides patients with targeted educational content and rewards for achieving functional milestones, fostering a supportive community for individuals managing chronic pain. Upside Health's platform includes remote patient monitoring and engagement tools that enable clinicians to access valuable data, improving care outcomes while minimizing additional burdens on healthcare providers. By empowering both patients and clinicians, Upside Health aims to transform the assessment and treatment of chronic pain, ultimately enhancing the quality of care and reducing healthcare costs.

BioLum Sciences LLC, founded in 2015 and based in Dallas, Texas, specializes in the development and manufacturing of innovative medical devices and bioanalytical chemistry solutions aimed at managing chronic inflammatory diseases such as asthma, chronic obstructive pulmonary disease (COPD), hypertension, and heart failure. The company’s core product, the BioSense Airway Monitoring Device, enables patients to monitor airway inflammation through non-invasive analysis of biomarkers in exhaled breath condensate, allowing for reliable at-home assessments without complex breathing maneuvers. This device, paired with a mobile application, helps patients track symptoms, evaluate medication efficacy, and share data with healthcare providers. BioLum Sciences also offers a blood analysis device that utilizes a simple finger-prick test to measure nitric oxide and related metabolites, providing critical insights into endothelial function and cardiovascular health. With a focus on remote patient monitoring and personalized treatment plans, BioLum Sciences aims to enhance patient outcomes and streamline healthcare costs through innovative biomarker analysis.

Metagenomi, Inc. is a genetic medicines company focused on developing innovative gene editing systems to address genetic diseases. Incorporated in 2016 and headquartered in Emeryville, California, Metagenomi utilizes metagenomics and machine learning to discover novel genome editing technologies. By sourcing cellular machinery from previously uncharacterized organisms, the company creates a proprietary toolbox that includes programmable nucleases, base editors, and advanced integration systems like prime editing and CRISPR-associated transposases. These systems are designed to be ultra-small, efficient, and highly specific, minimizing the risk of immune responses. Metagenomi aims to revolutionize gene editing techniques and deliver curative therapeutics to patients worldwide.

BioSTL builds regional capacity and fosters collaborative efforts to advance innovation, entrepreneurship, and new company creation that capitalize on St. Louis’ world-class medical and plant biosciences. Through its work, BioSTL promotes economic growth and regional prosperity.

Aparito Limited is a health technology company based in Wrexham, United Kingdom, focused on digitizing clinical trials and enhancing drug development processes. Established in 2014, the company develops mobile applications and wearable devices that facilitate real-time patient monitoring outside of traditional healthcare settings. Its Atom5™ platform supports patient-centric clinical trials by capturing frequent patient-generated data through various methods, including video eCOAs, ePROs, wearables, and telemedicine. This innovative approach allows for continuous data collection, improving understanding of diseases and clinical trial outcomes while ensuring compliance with relevant regulations. By enabling patients and their caregivers to participate in research from home, Aparito aims to improve patient outcomes and streamline the drug development process.

S-There is a company that has developed an innovative passive medical device aimed at health monitoring and chronic disease management. It offers the world's first smart toilet device that tracks health metrics, specifically focusing on hydration. The device provides users with a comprehensive analysis of their hydration levels through a mobile application, allowing them to understand how environmental factors impact their hydration. By identifying trends in hydration quality, S-There empowers users to enhance their hydration practices and overall well-being through personalized insights delivered directly to their smartphones.

The Muny is a community outdoor musical performance and recreation center. In this studio, singers may perform without accompaniment or may be accompanied by any instrumental combination, from piano to full orchestra. They inspire people to praise. Likewise, using the choir for congregational songs is a powerful prompt to help worshipers clearly hear the melody and join their voices as one.

CoverCress Inc. is a biotechnology company based in Saint Louis, Missouri, founded in 2013. The company focuses on developing and commercializing field pennycress as an oilseed crop, which is utilized for producing oil for renewable fuels and meal for livestock feed. By genetically improving pennycress, CoverCress aims to create a sustainable cover crop that enhances soil health and offers benefits for farmers during corn and soybean planting seasons. The company’s efforts are centered on sustainable agricultural practices, allowing farmers to maximize yields while minimizing input and carbon emissions. Formerly known as Arvegenix Inc., CoverCress reflects a commitment to innovation in agriculture, biotechnology, and renewable energy solutions.

Sky Labs is a technology company focused on developing innovative wearable devices for health monitoring, particularly a cuffless ring-type blood pressure monitor and a device known as the Cardio Tracker (CART). The CART is designed for continuous monitoring of atrial fibrillation, a common and often undiagnosed heart condition affecting many individuals over 40. This device can be worn comfortably on any finger and is both waterproof and dustproof, allowing users to wear it throughout their daily activities without interruption. It operates without user intervention, automatically detecting and recording atrial fibrillation, which users can track via a smartphone application. The device aims not only to assist individuals in managing their heart health but also to provide valuable data to healthcare professionals for accurate diagnosis. Sky Labs is currently conducting clinical trials in collaboration with Seoul National University Hospital to validate the performance of its technology, with an initial focus on the atrial fibrillation patient market in Finland, and an extended target market of millions worldwide. The company is also partnering with Bayer to explore further healthcare innovations.

Boragen Inc. is a biotechnology company based in Durham, North Carolina, founded in 2015. It specializes in the design and development of multifunctional small molecule boron solutions for applications in crop protection, animal health, and human health. Boragen's innovative synthetic chemistry platform enables the production of next-generation fungicides, including BAG8, a multisite fungicide, and BN2266, which targets mRNA processing. The company is also developing a dual function nematicide-fungicide for root protection and endo-parasiticides that can overcome resistance. By leveraging the unique properties of boron, Boragen aims to create sustainable agricultural solutions that reduce the probability of fungicide resistance and minimize chemical usage while maintaining efficacy across various sectors.

Monsanto, a subsidiary of Bayer AG, is a global agricultural company that provides products to help farmers grow crops more efficiently. It operates in two segments: Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment offers a range of row crop and vegetable seeds, along with biotechnology traits that assist farmers in controlling insects and weeds. The Agricultural Productivity segment manufactures and sells herbicides for weed control. Monsanto markets its products through various channels, including distributors, retailers, cooperatives, and directly to farmers. The company aims to address global food challenges and promote sustainable agriculture.

proPlant Gesellschaft für Agrar- und Umweltinformatik

Precision agriculture web-based software to analyze productivity of your fields. Zoner.ag is a software solution created by IntelMax Corp. to organize, store, and analyze information in precision agriculture. The system carries out the analysis of satellite images, aerial imagery, yield monitor data and soil EC, terrain and other georeferenced data. In addition, Zoner.ag provides detailed real-time information about the weather in each field and allows for crop disease forecasting. Our technology helps to increase yield by 8-10%, efficiency of use of mineral fertilizers by up to 40%, and saves 20-30% of pesticides. More info at http://zoner.ag/

Dihon Pharmaceutical Group Co., Ltd., established in 1997 as a Sino-American joint venture, is based in the Kunming National New & High-Tech Industrial Development Zone. It was formed by Great Eastern Enterprises Inc. of the United States and Yunnan Dihon Pharmaceutical Group Co., Ltd. of China, which is the majority shareholder. The company specializes in the manufacturing of herbal Chinese medicines, offering a range of products that includes dandruff treatments, antifungal creams, and medications for gynecological conditions such as endometriosis. Dihon builds on the legacy of its predecessor, Yunnan Dihon Natural Pharmaceutical Factory, founded in 1993, to provide traditional herbal remedies that address various health concerns.

Merck Consumer Care (MCC) is the allergy-treatment Claritin and decongestant Afrin.

Algeta ASA is an oncology company headquartered in Oslo, Norway, that specializes in developing targeted therapies for cancer treatment using its proprietary alpha-pharmaceutical platform. Founded in 1997, the company focuses on fulfilling unmet medical needs in cancer care. Its lead product, radium-223 dichloride, has successfully completed Phase III clinical trials for treating castration-resistant prostate cancer with bone metastases. Additionally, Algeta is advancing its research on thorium-227, an alpha-emitter that is in the preclinical phase and is being developed in conjunction with tumor-targeting molecules to create targeted thorium conjugates. The company has a collaboration agreement with Bayer Pharma AG for the global development and commercialization of radium-223. Algeta was previously known as Anticancer Therapeutic Inventions AS before rebranding in 2003.

AgraQuest is a leading company specializing in innovative biological and low-chemical pest management solutions, primarily serving the agricultural and food safety markets. The company focuses on the discovery, development, manufacturing, and marketing of effective biopesticide products that enhance pest and disease control while minimizing environmental impact. By utilizing renewable, bio-based materials, AgraQuest's products offer sustainable alternatives to conventional pesticides. The company operates through its Agrochemical and BioInnovations Divisions, which are dedicated to advancing eco-friendly pest management and enhancing agricultural yields. AgraQuest’s offerings extend beyond agriculture to include applications in home and garden care, food safety, and diverse sectors such as healthcare and cosmetics. With a direct sales force in the NAFTA region and a network of distributors globally, AgraQuest is committed to providing customers with value-driven solutions that support sustainable agricultural practices.

Artificial Muscle Inc. is a Menlo Park, California-based company specializing in the development of polymer components that transform electrical energy into mechanical motion. The company manufactures electro-magnetic actuators and sensing components, providing lightweight alternatives to traditional actuators, motors, generators, sensors, and speakers. Its innovative products have applications across various sectors, including medical devices, robotics, and consumer electronics, enhancing functionality in smartphones, gaming controllers, and automotive systems. Additionally, Artificial Muscle Inc. offers a haptic driver solution that integrates seamlessly into multiple electronic devices, further expanding its impact in the technology landscape.

Direvo Industrial Biotechnology GmbH is a privately owned company based in Cologne, Germany, specializing in the development and marketing of biology-based products and processes for non-pharmaceutical applications. Founded in 2008, the company utilizes its expertise in enzymes, microbes, and process optimization to create bio-based solutions across various sectors, including clean energy, clean chemistry, and biomass conversion. Direvo offers a range of innovative platforms, such as the BluZy portfolio, designed for the grain ethanol industry, which includes products that enhance the nutritional value of bio-ethanol by-products and improve process efficiency in ethanol production. Additionally, the company provides the BluServ platform, focused on automated high-throughput screening for protein and strain engineering, and the BluCon technology platform, which converts non-food feedstocks into carbohydrates for fuel and chemical production. Direvo collaborates with global leaders in the industry to deliver customized solutions tailored to specific market needs.

Icon Genetics GmbH is an agricultural biotechnology company based in Halle, Germany, specializing in the discovery and development of biopharmaceuticals and protein products through the use of green plants as production hosts. Founded in 1999, the company has developed a range of innovative production platforms and prototypes targeting pharmaceutical, animal health, and chemical biotech markets. Its offerings include the Transgene Operating Systems, which utilize advanced technologies such as nuclear transformation and plastid transformation for high-yield production of specialty proteins. Additionally, the company provides systems like magnICON for gene/vector assembly and optimization, lexICON for DNA bar-coding of genetically modified plants, and rubICON for hybrid seed production and trait control. Icon Genetics also develops antibodies and vaccines, enhancing its portfolio in the biopharmaceutical sector. The company operates subsidiaries in both Germany and the United States.

Zeptosens is an ultra-sensitive microarray platform for quantitative proteomic investigations. It provides microarray platforms for sensitive and quantitative protein profiling, and signaling pathway analysis by reverse protein arrays. Its products include ZeptoREADER, a microarray reader for Zeptosens planar wave guide technology; ZeptoMARK protein microarray chips and ZeptoCARRIER for various data points, which are split into arrays. The company also offers proteinarray services, including protein profiling for various samples, such as cell lines, tissues, microdissected cells, and depleted serums; and assay development. In addition, it provides training services, technical and applications support, and technical service and maintenance. The company’s products are used in various applications, including biomarker/target discovery and validation, cell-based screening, mode of action profiling, selectivity profiling, and toxicology investigation. Its customers include pharma research and development companies, biotech companies, and academic institutions. Zeptosens was founded in 2002 and is headquartered in Wilderswil, Switzerland.

yet2.com provides intellectual property consulting and licensing services to world-class clients around the globe. Yet2.com Inc. and its online marketplace were founded in 1999 to promote Open Innovation, with original investments from Siemens, Bayer, Honeywell, DuPont, Procter & Gamble, Caterpillar, and NTT Leasing. The privately held company has offices in the United States, Europe, and Japan. The web site now has over 120,000 registered marketplace users including many of the Fortune 500 and over 16,000 smaller technology companies. In addition to its core team, yet2.com has created a wide network of Open Innovation partners covering many of the technology-rich countries around the world as well as relationships with open innovation organizations, technical expert networks, SME networks, technical magazines, online technical communities, and technology brokers. These provide market-wide access to technologies and needs in countries such as Russia, China, India, Korea, Brazil, South Africa, Japan, the US, and the EU.